The pharmacokinetics and the pharmacodynamic effect of ODM-208, an inhibitor of cholesterol side-chain cleavage enzyme (CYP11A1)
Authors
Bernard-Tessier, A.Nykanen, P.
Utriainen, T.
Cook, Natalie
Barthelemy, P.
Baldini, C.
Peters, Niamh
Ikonen, T.
Pohjanjousi, P.
Karimaa, M.
Malkki, J.
Toivanen, P. T.
Garratt, C.
Fizazi, K.
Affiliation
Oncology, Institut Gustave Roussy, 94805 - Villejuif/FRIssue Date
2022
Metadata
Show full item recordCitation
Bernard-Tessier A, Nykanen P, Utriainen T, Cook N, Barthelemy P, Baldini C, et al. The pharmacokinetics and the pharmacodynamic effect of ODM-208, an inhibitor of cholesterol side-chain cleavage enzyme (CYP11A1). Annals of Oncology. 2022 Sep;33(7):S1194-S. PubMed PMID: WOS:000866211601677.Journal
Annals of OncologyDOI
10.1016/annonc/annonc1070Additional Links
https://dx.doi.org/10.1016/annonc/annonc1070Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/annonc/annonc1070